Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.58 |
| ▸ | CA2 | P00918 | 2/20 | 0.58 |
| ▸ | CA9 | Q16790 | 2/20 | 0.58 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.49 |
| ▸ | RAB9A | P51151 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | PKM | P14618 | 2/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30559973 | 1.00 | CA1 (0.58) | CA1CA2CA9RXFP1HDAC1 | |
| SCHEMBL1116454 | 0.87 | CA1 (0.47) | CA1CA2CA9RXFP1HDAC1 | |
| SCHEMBL375020 | 0.85 | RXFP1 (0.50) | CA1CA2CA9RXFP1HDAC1 | |
| SCHEMBL30005976 | 0.85 | RXFP1 (0.50) | CA1CA2CA9RXFP1HDAC1 | |
| SCHEMBL17938258 | 0.85 | HTT (0.53) | CA1CA2CA9RXFP1NPC1 | |
| SCHEMBL3909893 | 0.83 | NPC1 (0.51) | CA1CA2CA9RXFP1HDAC1 | |
| SCHEMBL1116483 | 0.83 | ALDH1A1 (0.52) | CA1CA2CA9RXFP1NPC1 | |
| SCHEMBL23997341 | 0.82 | HPGD (0.51) | CA1CA2CA9RXFP1NPC1 | |
| SCHEMBL30336857 | 0.82 | HPGD (0.51) | CA1CA2CA9RXFP1NPC1 | |
| SCHEMBL29025602 | 0.82 | NPC1 (0.44) | CA1CA2CA9RXFP1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113912534-B | Biphenyl heterocyclic compound, synthesis method and application thereof | 江苏科技大学 | 2023-07-25 | — | — | CN | claimed |
| CN-111217718-B | Sulfur-free 2-bromo-4-fluoroacetanilide synthesis method | 安徽东健化工科技有限公司 | 2023-06-16 | — | — | CN | claimed |
| WO-2023083161-A1 | BIPHENYL HETEROCYCLIC COMPOUND, AND SYNTHESIS METHOD THEREFOR AND USE THEREOF | 江苏科技大学 | 2023-05-19 | — | — | WO | claimed |
| CN-114441584-A | Analysis method for content of acetate in lithium electrolyte | 中船(邯郸)派瑞特种气体股份有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-114163346-A | Synthesis method of o-bromo-p-fluoroacetanilide | 宁夏常晟药业有限公司 | 2022-03-11 | — | — | CN | claimed |
| CN-113912534-A | Biphenyl heterocyclic compound, and synthesis method and application thereof | 江苏科技大学 | 2022-01-11 | — | — | CN | claimed |
| CN-111217718-A | Synthesis method of sulfur-free 2-bromo-4-fluoroacetanilide | 安徽东健化工科技有限公司 | 2020-06-02 | — | — | CN | claimed |
| CN-108440312-B | Preparation method of 2- (3,4) -dichlorophenyl-4-fluoroaniline | 江苏科技大学 | 2020-05-01 | — | — | CN | claimed |
| EP-3024836-B1 | IMPROVED METHOD FOR THE PREPARATION OF CHLORINATED BIPHENYLANILIDES AND BIPHENYLANILINES | BAYER CROPSCIENCE AG (DE) | 2018-07-11 | — | — | EP | claimed |
| US-20180093942-A1 | PROCESS FOR PREPARING CHLORINATED BIPHENYLANILIDES AND BIPHENYLANILINES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-04-05 | — | — | US | claimed |
| CN-102320987-A | Preparation method of 2-bromo-4-fluoroacetanilide | ANHUI DONGJIAN CHEMICAL INDUSTRY CO LTD | 2012-01-18 | — | — | CN | claimed |
| CN-102295572-A | Design method for industrial process of 2-bromine-4-fluoroacetanilide | — | 2011-12-28 | — | — | CN | claimed |
| CN-102120723-A | Preparation method of 2-br-4-fluoacetanilide | JINKAI LIAONING CHEMICAL CO LTD | 2011-07-13 | — | — | CN | claimed |
| US-20110105796-A1 | Tetraarylborate Process for the Preparation of Substituted Biphenyls | BAYER CROPSCIENCE AG (DE) | 2011-05-05 | — | — | US | claimed |
| US-20110092736-A1 | Process for Preparing Substituted Biphenylanilides | BAYER CROPSCIENCE AG (DE) | 2011-04-21 | — | — | US | claimed |
| CN-102015625-A | Process for preparing substituted biphenylanilides | BAYER CROPSCIENCE AG | 2011-04-13 | — | — | CN | claimed |
| WO-2011023324-A1 | TETRAARYLBORATE PROCESS FOR PRODUCING SUBSTITUTED BIPHENYLS | BAYER CROPSCIENCE AG (DE) | 2011-03-03 | — | — | WO | claimed |
| EP-2280932-A1 | PROCESS FOR PREPARING SUBSTITUTED BIPHENYLANILIDES | Bayer CropScience AG (DE) | 2011-02-09 | — | — | EP | claimed |
| EP-2119697-A1 | Process for preparing substituted biphenylanilides | Bayer CropScience AG (DE) | 2009-11-18 | — | — | EP | claimed |
| WO-2009135598-A1 | PROCESS FOR PREPARING SUBSTITUTED BIPHENYLANILIDES | BAYER CROPSCIENCE AG | 2009-11-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105796-A1 | Tetraarylborate Process for the Preparation of Substituted Biphenyls | AHR, DDT, CYP4F3 | CA1 4783/4885CA2 4722/4885CA9 3146/4885 |
| US-20180093942-A1 | PROCESS FOR PREPARING CHLORINATED BIPHENYLANILIDES AND BIPHENYLANILINES | DDT, CBR3, MSRB3 | CA1 2749/4885CA2 1852/4885CA9 1878/4885 |
| US-20110092736-A1 | Process for Preparing Substituted Biphenylanilides | CYP1B1, DDT, ABL1 | CA1 4128/4885CA2 4289/4885CA9 3282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.